Observations on the Drug resistance of Tubercle Bacilli before and after Anti-tuberculous Chemotherapy.
スポンサーリンク
概要
- 論文の詳細を見る
The authors studied on the drug-resistance of tubercle bacilli in sputa of 340 patients admitted to this hospital from January, 1958 to September, 1960. "Complete resistance " was adopted, e.g. 1 γ streptomycin resistance indicates that there was as much growth of tubercle bacilli on medium with 1 r streptomycin per ml as in the control medium. Results obtained were as follow:<BR>1) Streptomycin (S.M)-, para-aminosalicylicacid (P A S) or isoniazid (INH) resistant strains of tubercle bacilli were found in sputa of 46 patients with untreated pulmonary tuberculosis in the following percentages: 6.5 % to 10 γ or more of S M, 6.6 % to 1 γ or more of PAS and 3.1 % to 1 γ or more of INH.<BR>2) Incidence of drug-resistant bacilli was examined in 48 patients with moderately or far advanced pulmonary tuberculosis who had received no prior anti-tuberculous drug therapy. The strains of tubercle bacilli cultured from the sputa of patients were uniformly sensitive to SM, PAS and INH at the time of initiation of treatment. After 180 days therapy with two (SM-PAS, SM-INH, PAS-INH) or three drugs (SM-PAS-INH), combined the incidence bacilli resistant to 10 γ or more of S M was 27.1%; 4.4% became resistant to 10 γ or more of P A S and 14.6% resistant to 1 γ or more of INH. Those cases without drug-resist ance at the end of the first course of therapy were treated with the second 180 day course, by the end of which 44.1% became resistant to 10 γ or more of SM, 15.3% to 10 γ or more of PAS and 16.6% to 1 γ or more of INH.<BR>3) Changes of drug-resistance of tubercle bacilli in the sputa of patients before and after anti-tuberculous drug therapy for 180 days were divided into three groups; i.e. increased, decreased and unchanged. In the authors' opinion, it might be meaningless to examine the resistance to 1 γ PAS or 0.1 γ INH and that bacilli with these low resistance should be included in the unchanged group, because many bacilli resistant to 1 γ PAS or 0.1 γ INH lost theirresistance after further administration of each drug. As for SM., too, 1 γ-resistance was equalized with 0 γ. Still it was to be noted that drug resistant bacilli often showed a decrease in their resistance in spite of continued adminis tration of the same drug, and an increase of drug resistance regardless of discontinuance of the therapy.<BR>4) Concerning the relation between the changes of drug resistance of bacilli and those of the clinical status after 180 days anti-tuberculous drug therapy, more cases with increasing than with decreasing drug resistance were found in the cases with increased number of discharged bacilli or those impaired in summarized judgement ; but no remarkable correlation was found between changes of drug resistance of bacilli and those of roentgenographic findings.
- 一般社団法人 日本結核病学会の論文
著者
-
鉄谷 多美子
関西医大第一内科
-
岡本 緩子
関西医大第1内科
-
完岡 市光
関西医大第一内科
-
高野 久子
関西医大附属牧野病院
-
黒川 伝太郎
関西医大附属牧野病院
-
橋本 仙一郎
関西医大附属牧野病院
-
大久 保滉
関西医大第一内科
-
藤本 安男
関西医大第一内科
-
楠野 弥与子
関西医大第一内科
-
川原 福江
関西医大第一内科
-
西川 浩
関西医大第一内科
-
大沢 清
関西医大第一内科
-
氷室 一郎
関西医大附属牧野病院
-
小林 はる枝
関西医大附属牧野病院
-
向原 笑子
関西医大附属牧野病院
-
今林 誠一
関西医大附属牧野病院
-
窪田 温子
関西医大附属牧野病院
-
中川 圭子
関西医大附属牧野病院
-
岡本 緩子
関西医大第一内科
関連論文
- 73.薬物過敏症における過敏薬物の体外検出(in vitro test)について(アレルギー・免疫学的診断法)
- 自己白血球感作による血中抗白血球抗体の検索(免疫血液疾患の血清学的研究 : 第2回免疫血液疾患の血清学的研究班班会議記録)
- 2型糖尿病における糖尿病性腎症の長期臨床検討第二報-糖尿病性網膜症の臨床経過-
- 9.糖尿病における不定愁訴と自律神経障害の関連について(一般演題)(第10回日本心身医学会近畿地方会演題抄録)
- 腎疾患に対する血管強化剤,Corbazochrome Sodium Sulfonateの大量投与の臨床経験 : 第24回日本循環器学会近畿地方会総会
- 3. 抗白血球抗体の検索 : 自己白血球並びに同種, 異種白血球による感作実験を主として(免疫血液疾患の血清学的研究 : 第4回班会議記録(昭和39年12月5日))
- I-A-30 尿中微量アルブミン測定の臨床的意義 : 糖尿病性腎症の早期診断と予防対策(第 2 報)
- I-A-3 糖尿病性細血管障害の臨床的検討血小板凝集能, 血液粘度の経時的変化(第 1 報)
- Observations on the Drug resistance of Tubercle Bacilli before and after Anti-tuberculous Chemotherapy.